Evidence map›Paper›PMID 40206703›Full record

ArticleFrontiers in artificial intelligence2025

MoSViT: a lightweight vision transformer framework for efficient disease detection via precision attention mechanism.

Yuanqi Chen, Aiping Wang, Ziyang Liu, Jie Yue, Enxu Zhang, Fei Li, Ning Zhang

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuanqi ChenSchool of Mechanical Engineering, Xijing University, Xi'an, China.
Aiping WangSchool of Electronic Information, Xijing University, Xi'an, China.
Ziyang LiuSchool of Mechanical Engineering, Xijing University, Xi'an, China.
Jie YueSchool of Mechanical Engineering, Xijing University, Xi'an, China.
Enxu ZhangSchool of Mechanical Engineering, Xijing University, Xi'an, China.
Fei LiSchool of Mechanical Engineering, Xijing University, Xi'an, China.
Ning ZhangSchool of Mechanical Engineering, Xijing University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maize, a globally essential staple crop, suffers significant yield losses due to diseases. Traditional diagnostic methods are often inefficient and subjective, posing challenges for timely and accurate pest management. This study introduces MoSViT, an innovative classification model leveraging advanced machine learning and computer vision technologies. Built on the MobileViT V2 framework, MoSViT integrates the CLA focus mechanism, DRB module, MoSViT Block, and the LeakyRelu6 activation function to enhance feature extraction accuracy while reducing computational complexity. Trained on a dataset of 3,850 images encompassing Blight, Common Rust, Gray Leaf Spot, and Healthy conditions, MoSViT achieves exceptional performance, with classification accuracy, Precision, Recall, and F1 Score of 98.75%, 98.73%, 98.72%, and 98.72%, respectively. These results surpass leading models such as Swin Transformer V2, DenseNet121, and EfficientNet V2 in both accuracy and parameter efficiency. Additionally, the model's interpretability is enhanced through heatmap analysis, providing insights into its decision-making process. Testing on small sample datasets further demonstrates MoSViT's generalization capability and potential for small-sample detection scenarios.

Indexed as

deep learningfew-shot object detectionmaize disease detectionMobileViT V2parallel attention mechanismprecision attention

Identifiers

PMID40206703
PMCPMC11979205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.